Document is current
Any future updates will be listed below
-
Authors
Bonanini, Flavio https://orcid.org/0000-0003-4065-5362
Kurek, Dorota https://orcid.org/0000-0002-7168-8944
Previdi, Sara
Nicolas, Arnaud https://orcid.org/0000-0001-9333-770X
Hendriks, Delilah https://orcid.org/0000-0003-1159-5946
de Ruiter, Sander
Meyer, Marine
Clapés Cabrer, Maria https://orcid.org/0000-0001-9943-6514
Dinkelberg, Roelof
García, Silvia Bonilla
Kramer, Bart https://orcid.org/0000-0003-3923-7112
Olivier, Thomas
Hu, Huili
López-Iglesias, Carmen
Schavemaker, Frederik
Walinga, Erik
Dutta, Devanjali https://orcid.org/0000-0002-4993-9639
Queiroz, Karla
Domansky, Karel
Ronden, Bob
Joore, Jos https://orcid.org/0000-0002-2744-4862
Lanz, Henriette L. https://orcid.org/0000-0002-4087-0313
Peters, Peter J. https://orcid.org/0000-0002-2964-5684
Trietsch, Sebastiaan J. https://orcid.org/0000-0003-1000-4139
Clevers, Hans https://orcid.org/0000-0002-3077-5582
Vulto, Paul https://orcid.org/0000-0002-1525-1545
-
Funding
Funding for this research was provided by:
H2020 Innovation In SMEs (848429)
Interreg (433)
H2020 Marie Skłodowska-Curie Actions (641639, 812616)
- License Information
-
More Information
Article History
Received: 16 November 2021
Accepted: 14 May 2022
First Online: 15 June 2022
Declarations
:
: Paul Vulto, Dorota Kurek, Flavio Bonanini, Sara Previdi, Sander de Ruiter, Bart Kramer, Rumaisha Annida, Silvia Bonilla García, Karla Queiroz, Marine Meyer, Maria Clapés Cabrer, Roelof Dinkelberg, Thomas Olivier, Arnaud Nicolas, Karel Domansky, Erik Walinga, Jos Joore, Henriette L. Lanz, Sebastiaan J. Trietsch, and Bob Ronden are employees of Mimetas BV, which is marketing the OrganoPlate Graft and Paul Vulto, Jos Joore, and Sebastiaan J. Trietsch are shareholders of Mimetas BV. OrganoPlate is a registered trademark of Mimetas BV. Hans Clevers is inventor on several patents related to organoid technology; his full disclosure is given at . Since March 2022, HC is Head of Pharma Research and Early Development (pRED) of F. Hoffmann-La Roche Ltd, Basel, Switzerland. The authors have no additional financial interests.
